학술논문

Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study
Document Type
Article
Source
In: The Lancet Haematology. (The Lancet Haematology, February 2024, 11(2):e136-e146)
Subject
Language
English
ISSN
23523026